Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Kissei, Servier expand licensing agreement for antidiabetic drug

Jan. 7, 1997

Amgen, Progenitor sign agreement covering leptin receptor technology

Jan. 7, 1997

Clinical results reported for Vivus' MUSE

Jan. 7, 1997

Procrit cleared for new indication

Jan. 3, 1997

New HRT patch approved for launch in U.S.

Jan. 3, 1997

Generic antidiabetic agent approved by FDA

Jan. 3, 1997

FDA advisory panel to discuss penile implant guidelines

Jan. 3, 1997

Lipid effects of two gestodene/ethinylestradiol combinations compared

Jan. 3, 1997

Fluoxetine plus dexfenfluramine effective in obese patients

Jan. 3, 1997

Lilly claims IGF-1 superagonists

Jan. 3, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.